120 Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 61

  • Portfolio
  • 28

  • Exits
  • 33

Exits

120 Capital General Information

Company Description

120 Capital is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in life sciences and healthcare sector startups.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 800 Boylston Street
  • Suite 410 Prudential Center
  • Boston, MA 02199
  • United States
+1 (857)

120 Capital Investments (61)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Dewpoint Therapeutics 13-Jul-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 1
Parabilis Medicines 23-Jan-2025 Drug Discovery Generating Revenue/Not Profitable
VFLO Medical 03-Dec-2024 Medical Supplies Generating Revenue
Joint Venture (Inari Medical / 6 Dimensions Capital / VFLO Medical / 120 Capital) 02-Dec-2024 Medical Supplies Generating Revenue
Sironax 13-Sep-2024 Drug Discovery Clinical Trials - General
Halda Therapeutics 31-Jul-2024 Drug Discovery Generating Revenue
Ultivue 25-Jul-2024 Other Healthcare Technology Systems Generating Revenue
Neuspera 18-Jun-2024 Therapeutic Devices Generating Revenue
Centrexion Therapeutics 27-Nov-2023 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Engine Biosciences 31-Oct-2023 Later Stage VC Drug Discovery Clinical Trials - General
You’re viewing 10 of 61 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

120 Capital Exits (33)

Company Name Exit Date Exit Type Exit Size
Parabilis Medicines 10-Jun-2026 IPO
Immunitas Therapeutics 12-May-2026
Medeor Therapeutics 01-Feb-2026
Halda Therapeutics 26-Dec-2025
iTeos Therapeutics 29-Aug-2025
Ultivue 09-Oct-2024
Refuge Biotech 03-Aug-2023
Cutia Therapeutics 09-Jun-2023
AltheaDx 26-Apr-2022 Merger/Acquisition
GRAIL 18-Aug-2021 Merger/Acquisition
You’re viewing 10 of 33 exits. Get the full list »

120 Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore 120 Capital‘s full profile, request access.

Request a free trial

120 Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

120 Capital FAQs

  • What is 120 Capital?

    120 Capital is a venture capital firm based in Boston, Massachusetts.

  • Where is 120 Capital headquartered?

    120 Capital is headquartered in Boston, MA.

  • What is 120 Capital's total asset value?

    120 Capital has around in total assets under management.

  • How many investments has 120 Capital made?

    120 Capital has made 61 investments.

  • What has 120 Capital invested in?

    120 Capital has made numerous investments in companies like Dewpoint Therapeutics, Parabilis Medicines, and VFLO Medical within the Drug Discovery and Medical Supplies industries.

  • What has 120 Capital invested in recently?

    120 Capital's latest investment was on 13-Jul-2026 in Dewpoint Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process